News
Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results